Wen, P., Alexander, B., Berry, D., Buxton, M., Cavenee, W., Colman, H., … Lassman, A. (2023). GBM AGILE PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GBM: RESULTS OF FIRST EXPERIMENTAL ARM, REGORAFENIB. In NEURO-ONCOLOGY (Vol. 25).

Wen, Patrick, Brian Alexander, Donald Berry, Meredith Buxton, Webster Cavenee, Howard Colman, John de Groot, et al. “GBM AGILE PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GBM: RESULTS OF FIRST EXPERIMENTAL ARM, REGORAFENIB.” In NEURO-ONCOLOGY, Vol. 25, 2023.

Wen P, Alexander B, Berry D, Buxton M, Cavenee W, Colman H, et al. GBM AGILE PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GBM: RESULTS OF FIRST EXPERIMENTAL ARM, REGORAFENIB. In: NEURO-ONCOLOGY. 2023.

Wen, Patrick, et al. “GBM AGILE PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GBM: RESULTS OF FIRST EXPERIMENTAL ARM, REGORAFENIB.” NEURO-ONCOLOGY, vol. 25, 2023.

Wen P, Alexander B, Berry D, Buxton M, Cavenee W, Colman H, de Groot J, Ellingson B, Gordon G, Hyddmark E, Khasraw M, Lim M, Mellinghoff I, Mikkelsen T, Perry J, Powell A, Sulman E, Tanner K, Weller M, Yung WKA, Blondin N, Brenner A, Butt O, de la Fuente M, Drappatz J, Iwamoto F, Kim L, Lee E, Mantica M, Nabors B, Newton H, Schiff D, Walbert T, Weathers S-P, Cloughesy T, Lassman A. GBM AGILE PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GBM: RESULTS OF FIRST EXPERIMENTAL ARM, REGORAFENIB. NEURO-ONCOLOGY. 2023.